Bio-Rad Laboratories Class A
437 hedge funds and large institutions have $6.5B invested in Bio-Rad Laboratories Class A in 2024 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 133 increasing their positions, 169 reducing their positions, and 68 closing their positions.
41% more call options, than puts
Call options by funds: $6.56M | Put options by funds: $4.64M
20% more capital invested
Capital invested by funds: $5.41B → $6.5B (+$1.09B)
0.72% more ownership
Funds ownership: 84.5% → 85.21% (+0.72%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 68 | Existing positions closed: 68
0% less funds holding
Funds holding: 439 → 437 (-2)
21% less repeat investments, than reductions
Existing positions increased: 133 | Existing positions reduced: 169
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VanEck Associates
New York
|
+$205M |
| 2 |
Millennium Management
New York
|
+$183M |
| 3 |
BlackRock
New York
|
+$120M |
| 4 |
AI
Ariel Investments
Chicago,
Illinois
|
+$87.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$79.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$161M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$148M |
| 3 |
Ninety One (UK)
London,
United Kingdom
|
-$106M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$93.5M |
| 5 |
State Street
Boston,
Massachusetts
|
-$71.1M |
BIO Hedge Fund Activity: Q3 2024 in Review
437 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2024, worth a combined $6.5B — up 20% from $5.41B a quarter earlier.
Fund positioning in BIO was balanced in Q3 2024: 68 funds opened new positions, 68 closed out, 133 added to existing stakes and 169 trimmed.
The largest buyer was VanEck Associates, adding an estimated $205M. The largest seller was Invesco, cutting an estimated $161M.
- 437 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2024, down from 439 in Q2 2024.
- Funds reported $6.5B of Bio-Rad Laboratories Class A stock for Q3 2024, up 20% quarter-over-quarter.
- 68 funds opened new Bio-Rad Laboratories Class A positions in Q3 2024 and 68 closed out, a net change of 0 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2024 was VanEck Associates, an estimated $205M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2024 was Invesco, an estimated $161M sold.
Based on aggregated 13F filings for Q3 2024.